Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Dec 16 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 3 pages · English

Release

Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 16, 2021, titled "Zydus receives Orphan Drug Designation from US FDA for ZY-19489, a novel compound to treat malaria".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases